Institutional & Family Asset Management »

Dianthus Therapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $90 3 30.00
2023-12-31 $30 3 10.33
2023-09-30 $41 3 13.67

More positions owned by Institutional & Family Asset Management

Ishares Tr Core Msci Eafe (IEFA)
Listed Fd Tr Core Alt Fd (CCOR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr U.s. Real Es Etf (IYR)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Inv Cp Etf (LQD)

View all positions for Institutional & Family Asset Management

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics